Ilia I. Ouspenski

Array ( [id] => 5125502 [patent_doc_number] => 20070237773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'HUMAN SEMA4A PROTEIN ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/625386 [patent_app_country] => US [patent_app_date] => 2007-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9837 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237773.pdf [firstpage_image] =>[orig_patent_app_number] => 11625386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477052 [patent_doc_number] => 20100285030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Antibodies to Ox-2/Cd200 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/087683 [patent_app_country] => US [patent_app_date] => 2007-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 31837 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285030.pdf [firstpage_image] =>[orig_patent_app_number] => 12087683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6516536 [patent_doc_number] => 20100261660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Novel co-stimulatory molecules' [patent_app_type] => utility [patent_app_number] => 11/645361 [patent_app_country] => US [patent_app_date] => 2006-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 116297 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261660.pdf [firstpage_image] =>[orig_patent_app_number] => 11645361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 246750 [patent_doc_number] => 07585501 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-08 [patent_title] => 'Compositions and methods for treating kidney disease' [patent_app_type] => utility [patent_app_number] => 11/613658 [patent_app_country] => US [patent_app_date] => 2006-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11405 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585501.pdf [firstpage_image] =>[orig_patent_app_number] => 11613658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6412804 [patent_doc_number] => 20100166774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Stable Protein Formulations' [patent_app_type] => utility [patent_app_number] => 12/086876 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25562 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166774.pdf [firstpage_image] =>[orig_patent_app_number] => 12086876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5095552 [patent_doc_number] => 20070117161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Antibody Specific for Human 4-1BB Receptor' [patent_app_type] => utility [patent_app_number] => 11/609263 [patent_app_country] => US [patent_app_date] => 2006-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6860 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117161.pdf [firstpage_image] =>[orig_patent_app_number] => 11609263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 232918 [patent_doc_number] => 07598345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'Immunostimulatory compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/635066 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 35 [patent_no_of_words] => 34097 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598345.pdf [firstpage_image] =>[orig_patent_app_number] => 11635066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5159460 [patent_doc_number] => 20070172504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'In vivo cell surface engineering' [patent_app_type] => utility [patent_app_number] => 11/635075 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 21960 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172504.pdf [firstpage_image] =>[orig_patent_app_number] => 11635075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 81349 [patent_doc_number] => 07745215 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Methods and compositions for expanding T regulatory cells' [patent_app_type] => utility [patent_app_number] => 11/635087 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 33 [patent_no_of_words] => 26031 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745215.pdf [firstpage_image] =>[orig_patent_app_number] => 11635087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 168779 [patent_doc_number] => 07666991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Compositions for needleless delivery of antibodies' [patent_app_type] => utility [patent_app_number] => 11/635230 [patent_app_country] => US [patent_app_date] => 2006-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 44488 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666991.pdf [firstpage_image] =>[orig_patent_app_number] => 11635230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367125 [patent_doc_number] => 20090304684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'METHODS AND COMPOSITIONS FOR NEEDLELESS DELIVERY OF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/096011 [patent_app_country] => US [patent_app_date] => 2006-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 44456 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304684.pdf [firstpage_image] =>[orig_patent_app_number] => 12096011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5131142 [patent_doc_number] => 20070207539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Rapid production of monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 11/600595 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 29374 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207539.pdf [firstpage_image] =>[orig_patent_app_number] => 11600595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 310949 [patent_doc_number] => 07527972 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'Uses of bispecific antibody coated dendritic cells pulsed with antigens and GM-CSF in immune regulation' [patent_app_type] => utility [patent_app_number] => 11/560649 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 35 [patent_no_of_words] => 35471 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/527/07527972.pdf [firstpage_image] =>[orig_patent_app_number] => 11560649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5106561 [patent_doc_number] => 20070065438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Methods of inducing and maintaining immune tolerance' [patent_app_type] => utility [patent_app_number] => 11/599798 [patent_app_country] => US [patent_app_date] => 2006-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12598 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065438.pdf [firstpage_image] =>[orig_patent_app_number] => 11599798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32903 [patent_doc_number] => 07785806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Method for determining the immunogenicity of an antigen' [patent_app_type] => utility [patent_app_number] => 11/594172 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4546 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785806.pdf [firstpage_image] =>[orig_patent_app_number] => 11594172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 216794 [patent_doc_number] => 07611702 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'TNF-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy' [patent_app_type] => utility [patent_app_number] => 11/557835 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4742 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/611/07611702.pdf [firstpage_image] =>[orig_patent_app_number] => 11557835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5246950 [patent_doc_number] => 20070243184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'PROPHYLAXIS AND TREATMENT OF ENTEROCOLITIS ASSOCIATED WITH ANTI-CTLA-4 ANTIBODY THERAPY' [patent_app_type] => utility [patent_app_number] => 11/557844 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5652 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243184.pdf [firstpage_image] =>[orig_patent_app_number] => 11557844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219750 [patent_doc_number] => 20070161061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'NOVEL COMPOSITION AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 11/557256 [patent_app_country] => US [patent_app_date] => 2006-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 39357 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161061.pdf [firstpage_image] =>[orig_patent_app_number] => 11557256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056386 [patent_doc_number] => 20070059308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Human monoclonal antibodies against membrane proteins' [patent_app_type] => utility [patent_app_number] => 11/593957 [patent_app_country] => US [patent_app_date] => 2006-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 30385 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059308.pdf [firstpage_image] =>[orig_patent_app_number] => 11593957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5034147 [patent_doc_number] => 20070098686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Use of apoptotic cells ex vivo to generate regulatory T Cells' [patent_app_type] => utility [patent_app_number] => 11/555978 [patent_app_country] => US [patent_app_date] => 2006-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9615 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20070098686.pdf [firstpage_image] =>[orig_patent_app_number] => 11555978 [rel_patent_id] =>[rel_patent_doc_number] =>)